Skip to content

Study of Lactic Acid Bacteria for Inhibition of Blood Sugar Elevation after Sucrose Intake in Human

Study of Lactic Acid Bacteria for Inhibition of Blood Sugar Elevation after Sucrose Intake in Human - Study of Lactic Acid Bacteria for Inhibition of Blood Sugar Elevation after Sucrose Intake in Human

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000024338
Enrollment
30
Registered
2016-10-08
Start date
2016-11-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults Borderline diabetes Type 2 diabetes

Interventions

Conduct sucrose tolerance test for both cases of intake and non-intake of lactic acid bacterium solution by 50ml (killed and viable bacteria) by taking an interval of about a week. Lactic acid bac

Sponsors

Pharmaspur Inc.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1) Japanese healthy (including borderline diabetes) male 2) Fasting blood sugar: Lower than 125 mg/dL 3) Subjects who is not a diabetes

Exclusion criteria

Exclusion criteria: 1) HbA1c are more than 7.0% 2) Subjects using medical products 3) Subjects who could start having allergic symptom in relation to test products 4) Subjects who use health food and supplements affecting blood glucose 5) Heavy drinker of alcohol 6) Subjects who participated in other clinical trials within the last four weeks prior to the current clinical trial 7) Subjects who have participated in a testregarding to the said lactic acid bacteriain the past. 8) Subjects judged inappropriate for the study by the investigator.

Design outcomes

Primary

MeasureTime frame
Blood glucose level after the sucrose tolerance test Area under the curve for blood glucose level

Countries

Japan

Contacts

Public ContactMichiko Kainuma

Pharmaspur Inc. -

michiko_kainuma@pharmaspur.com03-6214-2670

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026